Nanomed for implants

Nanomed­i­cine Market


Accord­ing to mar­ket ana­lysts [BCC], the global nanomed­i­cine sec­tor, which was worth $53 bil­lion in 2009, is pro­jected to grow at a com­pound annual growth rate (CAGR) of 13.5%, sur­pass­ing $100 bil­lion in 2014 (see Fig­ure 1).

staric 3

This graph shows the global nanomed­i­cine mar­ket size, mea­sured in terms of rev­enues, such as sales rev­enues, grants rev­enues, and mile­stones. From 2006 to date, a steady growth has occurred, which is expected to con­tinue through 2014, at a CAGR of 13.5% [BCC Research, “Nan­otech­nol­ogy in Med­ical Appli­ca­tions: The Global Mar­ket,” 2010, inception].

The drug deliv­ery mar­ket is the largest con­tribut­ing appli­ca­tion seg­ment, whereas bio­ma­te­ri­als is the fastest grow­ing appli­ca­tion area in this mar­ket. Nanomed­i­cine accounts for 77 Mar­keted Prod­ucts World­wide, rep­re­sent­ing an Indus­try with an esti­mated mar­ket $130.9 Bil­lion by 2016 [ETPN data, BCC].

One of the largest seg­ments of this mar­ket is rep­re­sented by drug deliv­ery sys­tems for the cen­tral ner­vous sys­tem, fol­lowed by anti-​infectious, anti-​inflammatory and anti­cancer prod­ucts. Anti­cancer nan­odrugs val­ued about $20 bil­lion in 2009, it is expected to reach $33 bil­lion in 2014, grow­ing at a CAGR of 11%. It is expected to reach $12.7 bil­lion by 2016, a CAGR of 18.2% between years 2011 and 2016. In Fig­ure 2, a dia­gram on the nanomed­ical global sales in rela­tion to ther­a­peu­tic areas for the period 20092016 is presented.

staric 4

Fig­ure 2. This graph shows the nanomed­ical global sales in rela­tion to major ther­a­peu­tic areas for the period 20092016.

All rights reserved. Copy­righted by BL Nanobio­med 20142017.
Joomla tem­plates by Joomlashine